Integrated Diagnostics rallies $6.1 mln Series C
Seattle-based Integrated Diagnostics Inc, a molecular diagnostics company, has raised $6.1 million in Series C funding. The investors were Baird Capital and InterWest Partners.
6 January 2017•1 min read
